tirzepatide cvot trial In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT results: https://nej.md/4qd5rLx Cardiovascular Outcomes with Tirzepatide versus

Simultaneously, the supplement industry is moving to incorporate peptides into products capsules, protein powders, gummies under a regulatory framework that requires far less oversight than the compounding pathway

Natural phytochemicals as novel therapeutic strategies to prevent and treat parkinson's disease

NAD also aids in reducing inflammation and oxidative stress, which can further enhance your overall well-being

Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion

By enhancing intracellular hydroperoxides, especially hydrogen peroxide, decreasing reduced glutathione concentration, increasing cysteine oxidation, and activating protein kinases, oxidant stress can enhance the activity of transcription factors, such as the nuclear factor kappa B and activator protein-1, which are involved in the expression of cell surface adhesion molecules, growth factors, immunoreceptors, and cytokines